These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18607017)

  • 1. Segregation is not good for patients with cystic fibrosis.
    Geddes D
    J R Soc Med; 2008 Jul; 101 Suppl 1(Suppl 1):S36-8. PubMed ID: 18607017
    [No Abstract]   [Full Text] [Related]  

  • 2. Segregation is good for patients with cystic fibrosis.
    Conway S
    J R Soc Med; 2008 Jul; 101 Suppl 1(Suppl 1):S31-5. PubMed ID: 18607016
    [No Abstract]   [Full Text] [Related]  

  • 3. Furthering our understanding of pathogen transmission in cystic fibrosis.
    Saiman L
    Thorax; 2009 Nov; 64(11):921-2. PubMed ID: 19864537
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychological consequences of segregation resulting from chronic Burkholderia cepacia infection in adults with CF.
    Duff AJ
    Thorax; 2002 Sep; 57(9):756-8. PubMed ID: 12200517
    [No Abstract]   [Full Text] [Related]  

  • 5. [Quality of life role in the decision to isolate septic patients in geriatrics].
    Pividori I
    Soins Gerontol; 2001; (28):23. PubMed ID: 11992967
    [No Abstract]   [Full Text] [Related]  

  • 6. Of isolates and isolation: Pseudomonas aeruginosa in adults with cystic fibrosis.
    Geddes DM
    Lancet; 2001 Aug; 358(9281):522-3. PubMed ID: 11520516
    [No Abstract]   [Full Text] [Related]  

  • 7. Patient isolation in the high-prevalence setting: challenges with regard to multidrug-resistant gram-negative bacilli.
    Bhattacharya S; Das D; Bhalchandra R; Goel G
    Infect Control Hosp Epidemiol; 2013 Jun; 34(6):650-1. PubMed ID: 23651904
    [No Abstract]   [Full Text] [Related]  

  • 8. Segregation--the perspectives of young patients and their parents.
    Russo K; Donnelly M; Reid AJ
    J Cyst Fibros; 2006 May; 5(2):93-9. PubMed ID: 16448864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A decade of reduced gram-negative infections and mortality associated with improved isolation of burned patients.
    McManus AT; Mason AD; McManus WF; Pruitt BA
    Arch Surg; 1994 Dec; 129(12):1306-9. PubMed ID: 7986161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Segregation and use of nonshared care settings reduce the risk of multiresistant P. aeruginosa infection. Re: Davies et al., "Multiresistant Pseudomonas aeruginosa in a pediatric cystic fibrosis center: natural history and implications for segregation," Pediatr Pulmonol 2003;35:253-256.
    Festini F; Ballarin S; Loganes C
    Pediatr Pulmonol; 2003 Aug; 36(2):171; author reply 172. PubMed ID: 12833499
    [No Abstract]   [Full Text] [Related]  

  • 11. Infection control: reducing the psychological effects of isolation.
    Ward D
    Br J Nurs; 2000 Feb 10-23; 9(3):162-70. PubMed ID: 11033629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical devices for cystic fibrosis care may be portable reservoirs of potential pathogens.
    Linnane B; Collins L; Bussmann N; O'Connell NH; Dunne CP
    J Hosp Infect; 2017 Aug; 96(4):397-398. PubMed ID: 28535966
    [No Abstract]   [Full Text] [Related]  

  • 13. Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission.
    Saiman L; Siegel J;
    Am J Infect Control; 2003 May; 31(3 Suppl):S1-62. PubMed ID: 12762292
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe Achromobacter xylosoxidans infection and loss of sputum bacterial diversity in an adult patient with cystic fibrosis.
    Talbot NP; Flight WG
    Paediatr Respir Rev; 2016 Aug; 20 Suppl():27-9. PubMed ID: 27374622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nosocomial acquisition and transmission of antibiotic-resistant gram-negative organisms in the pediatric intensive care unit.
    Toltzis P; Blumer JL
    Pediatr Infect Dis J; 2001 Jun; 20(6):612-8. PubMed ID: 11419505
    [No Abstract]   [Full Text] [Related]  

  • 16. What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria?
    Harris AD; McGregor JC; Furuno JP
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S57-61. PubMed ID: 16894516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review.
    Festini F; Buzzetti R; Bassi C; Braggion C; Salvatore D; Taccetti G; Mastella G
    J Hosp Infect; 2006 Sep; 64(1):1-6. PubMed ID: 16835001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated instance.
    Gammon J
    Nurs Times; 1999 Jan 13-19; 95(2):57, 60. PubMed ID: 10067604
    [No Abstract]   [Full Text] [Related]  

  • 19. Pseudomonas cepacia infection in cystic fibrosis.
    Smith DL; Smith EG; Gumery LB; Stableforth DE
    Lancet; 1992 Jan; 339(8787):252. PubMed ID: 1370564
    [No Abstract]   [Full Text] [Related]  

  • 20. A point-prevalence study on healthcare-associated infections in Vietnam: public health implications.
    Thu TA; Hung NV; Quang NN; Archibald LK; Thuy le TT; Harun-Or-Rashid ; Sakamoto J
    Infect Control Hosp Epidemiol; 2011 Oct; 32(10):1039-41. PubMed ID: 21931257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.